Drug interactions in metastatic breast cancer. - Wikidata - wikimedia - TriplyDB

Drug interactions in metastatic breast cancer.

Drug interactions in metastatic breast cancer.

http://www.wikidata.org/entity/Q37791284

about

Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.

P2860

Q35023711-AFBEF938-8360-499C-89FC-14B2DBF01C35

P2860

Drug interactions in metastatic breast cancer.

http://www.wikidata.org/entity/Q37791284

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug interactions in metastatic breast cancer.

@en

Drug interactions in metastatic breast cancer.

@nl

type

label

Drug interactions in metastatic breast cancer.

@en

Drug interactions in metastatic breast cancer.

@nl

prefLabel

Drug interactions in metastatic breast cancer.

@en

Drug interactions in metastatic breast cancer.

@nl

P1433

Q37791284-17C9AA80-829C-4CCC-BFE2-DC86D8C49C74

P1476

Q37791284-D088C8E5-EA2C-47EB-AA74-C84FD7A3FAB3

P2093

Q37791284-B3850657-42F7-42C4-A959-16C03CDA739B

P2860

Q37791284-0A981A0B-8033-4B25-9410-7B9114C4554C

Q37791284-126BB9F1-42FD-4DA0-93F6-882009EE5DBD

Q37791284-142CD899-0599-4C4D-A6FD-CAE54C5BCCCD

Q37791284-15E69587-6D85-42C8-B62C-8399435681E2

Q37791284-2C36C477-B684-4C1E-B258-0FE7A3C68DA0

Q37791284-2E3312B1-5D3B-45A3-9425-63536F232C6D

Q37791284-317763FF-CA50-4A08-93D2-24CF4F0CC116

Q37791284-3834B6B0-68CE-49CD-AE9B-F189CDECFFFD

Q37791284-49E9AA8F-9307-44B3-BD2E-92DEFB498A35

Q37791284-5ACD69E1-C877-4855-8002-CA948B45E5D2

P304

Q37791284-036B2A0D-9B5C-4992-BD1F-8AD0E2FE8C44

P31

Q37791284-A3EF6376-CAD8-4D62-9F7B-41D773110C82

P356

Q37791284-87342A93-E966-46C9-ADE1-7D0E6F209D77

P433

Q37791284-03C90229-EA7D-408D-9D54-B28B82AF45F7

P478

Q37791284-4601AE37-AB35-4FBE-8AA2-A7F66254D6C6

P577

Q37791284-F08069F8-132E-4444-A739-3839A71C6A0D

P698

Q37791284-099AD3F6-2019-41B3-BCD0-5D4E949774F8

P356

1078155210379167

P1433

Journal of Oncology Pharmacy Practice

P1476

Drug interactions in metastatic breast cancer.

@en

P2093

Timothy Tyler

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice

Drug interactions in palliative care.

Changes in plasma protein binding have little clinical relevance.

Pharmacogenomics: unlocking the human genome for better drug therapy.

Clinical-pharmacological strategies to assess drug interaction potential during drug development.

Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

Herbal remedies in the United States: potential adverse interactions with anticancer agents.

Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

P304

236-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155210379167

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20861179

http://www.w3.org/2001/XMLSchema#string